The women's health space is emerging as one of the fastest-growing segments within the broader health and wellness industry; however, certain challenges persist. Historically, women have been underrepresented in clinical trials, leading to a lack of data specifically focused on female health conditions. Most nutraceutical and pharmaceutical products have been primarily studied in men only, resulting in an insufficient understanding of how these products affect women differently, leading to misdiagnoses, ineffective treatments, and adverse effects. As per the World Economic Forum’s “Closing the Women’s Health Gap 2024” report, US women have 52% more adverse events and 36% more serious or fatal events from approved medicines than men. Also, it mentions that women spend 25% more of their lives in poor health than men.

• How can your team close growth gaps by developing products that are safe and effective for women, particularly in areas such as reproductive health, hormonal balance, and menopause-induced bone health?

• Which growth prospects can help address the specific nutritional needs of women across different stages of life, from adolescence through the childbearing years to menopause and beyond?

• What are the game-changing opportunities showcasing immense growth potential across the women’s health ingredients industry?